As previously reported for diffuse large B-cell lymphoma (DLBCL) [23,24] and follicular lymphoma (FL) [25,26], pathogenic variants involving the CREBBP and EP300 genes seem to arise particularly frequently in patients with cHL showing chemorefractory disease (Figure 6). The gene discussed is CREBBP; the disease is diffuse large B-cell lymphoma.